References
- Ding X , GhobarahH, ZhangXet al. High-throughput liquid chromatography/mass spectrometry method for the quantitation of small molecules using accurate mass technologies in supporting discovery drug screening. Rapid Commun. Mass Spectrom. 27(3), 401–408 (2013).
- Kaufmann A , WalkerS. Evaluation of the interrelationship between mass resolving power and mass error tolerances for targeted bioanalysis using liquid chromatography coupled to high-resolution mass spectrometry. Rapid Commun. Mass Spectrom. 27(2), 347–356 (2013).
- Bruce SJ , RochatB, BéguinAet al. Analysis and quantification of vitamin D metabolites in serum by ultra-performance liquid chromatography coupled to tandem mass spectrometry and high-resolution mass spectrometry – a method comparison and validation. Rapid Commun. Mass Spectrom. 27(1), 200–206 (2013).
- Ojanperä I , KolmonenM, PelanderA. Current use of high-resolution mass spectrometry in drug screening relevant to clinical and forensic toxicology and doping control. Anal. Bioanal. Chem. 403(5), 1203–1220 (2012).
- Crews BO , PesceAJ, WestR, NguyenH, FitzgeraldRL. Evaluation of high-resolution mass spectrometry for urine toxicology screening in a pain management setting. J. Anal. Toxicol. 36(9), 601–607 (2012).
- Broecker S , HerreS, PragstF. General unknown screening in hair by liquid chromatography–hybrid quadrupole time-of-flight mass spectrometry (LC–QTOF-MS). Forensic. Sci. Int. 218(1–3), 68–81 (2012).
- Wu AH , GeronaR, ArmenianP, FrenchD, PetrieM, LynchKL. Role of liquid chromatography–high-resolution mass spectrometry (LC–HR/MS) in clinical toxicology. Clin. Toxicol. (Phila.)50(8), 733–742 (2012).
- Ma S , ChowdhurySK. Data acquisition and data mining techniques for metabolite identification using LC coupled to high-resolution MS. Bioanalysis5(10), 1285–1297 (2013).
- Wang H , BennettP. Performance assessment of microflow LC combined with high-resolution MS in bioanalysis. Bioanalysis5(10), 1249–1267 (2013).
- Wei H , TymiakAA, ChenG. High-resolution MS for structural characterization of protein therapeutics: advances and future directions. Bioanalysis5(10), 1299–1313 (2013).
- Zelesky V , SchneiderR, JaniszewskiJ, ZamoraI, FergusonJ, TroutmanM. Software automation tools for increased throughput metabolic soft-spot identification in early drug discovery. Bioanalysis5(10), 1165–1179 (2013).
- Huang M-Q . Lin Z, Weng N. Applications of high-resolution MS in bioanalysis. Bioanalysis5(10), 1269–1276 (2013).
- Fung EN , JemalM, AubryAF. High-resolution MS in regulated bioanalysis: where are we now and where do we go from here?. Bioanalysis5(10), 1277–1284 (2013).
- Ramanathan DM . Looking beyond the SRM to high-resolution MS paradigm shift for DMPK studies. Bioanalysis5(10), 1141–1143 (2013).
- Rochat B , FavreA, SottasPE. Metabotype analysis for personalized biology: a new bioanalytical territory for high-resolution MS. Bioanalysis5(10), 1149–1152 (2013).
- Campbell JL , RamagiriS. Recognizing the potential benefits and pitfalls of high-resolution MS. Bioanalysis5(10), 1157–1160 (2013).
- Dillen L , CuyckensF. High-resolution MS: first choice for peptide quantification?. Bioanalysis5(10), 1145–1148 (2013).
- Meyer MR . Do we need high-resolution MS in forensic and clinical toxicology?. Bioanalysis5(10), 1161–1163 (2013).
- Barbara JE , BuckleyDB, HorriganMJ. Exploring the utility of high-resolution MS with post-acquisition data mining for simultaneous exogenous and endogenous metabolite profiling. Bioanalysis5(10), 1211–1228 (2013).
- Morin L-P . Mess J-N, Garofolo F. Large-molecule quantification: sensitivity and selectivity head-to-head comparison of triple quadrupole with Q-TOF. Bioanalysis5(10), 1181–1193 (2013).
- Hnatyshyn S , ShipkovaP, SandersM. Expedient data mining for non-targeted high-resolution LC–MS profiles of biological samples. Bioanalysis5(10), 1195–1210 (2013).
- Voelker T , WangH, IrishMet al. Method development and validation of six bile acids for regulated bioanalysis: improving selectivity and sensitivity. Bioanalysis5(10), 1229–1248 (2013).